Operating across the People's Republic of China, China Life Insurance Company Limited, supported by its various subsidiaries, serves as a prominent provider of life insurance services. The company structures its extensive operations into four principal divisions: Life Insurance, Health Insurance, Accident Insurance, and a category for Other Businesses. It offers a wide array of protective insurance products, which include critical illness coverage, annuity schemes, specialized policies targeting children, women, and pension planning, in addition to general security, life, medical, and accident safeguards. The firm's origins trace back to 1949, and its central office is situated in Beijing, PRC. Ultimately, China Life Insurance Company Limited is an integral part of the China Life Insurance (Group) Company Limited, operating as one of its subsidiaries.
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange China Life Insurance stocks are traded under the ticker CILFY.
When is the next China Life Insurance earnings date?▼
China Life Insurance is going to release the next earnings report on April 1, 2027.
What were China Life Insurance earnings last quarter?▼
CILFY earnings for the last quarter are -0.24 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is China Life Insurance revenue for the last year?▼
China Life Insurance revenue for the last year amounts to 0 USD.
What is China Life Insurance net income for the last year?▼
CILFY net income for the last year is 21.89B USD.
How many employees does China Life Insurance have?▼
As of November 10, 2026, the company has 97,505 employees.
In which sector is China Life Insurance located?▼
China Life Insurance operates in the Finance & Payments sector.
When did China Life Insurance complete a stock split?▼
China Life Insurance has not had any recent stock splits.
Where is China Life Insurance headquartered?▼
China Life Insurance is headquartered in Beijing, China.